Lv4
580 积分 2021-02-09 加入
Type 2 diabetes mellitus
20小时前
待确认
The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
1个月前
已完结
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
1个月前
已完结
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
1个月前
已完结
Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?
2个月前
已完结
Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer
3个月前
已完结
Letter to Editor. Re "de Leeuw SP, et al. Analysis of Serious Weight Gain in Patients Using Alectinib for ALK Positive Lung Cancer," Semaglutide a Potential Treatment for Serious Weight Gain From ALK Tyrosine Kinase Inhibitors?
3个月前
已完结
The gut and energy balance: visceral allies in the obesity wars
6个月前
已完结
Pro-inflammatory immune microenvironment and Thrombospondin-1-positive monocytes as drivers of osteoclastogenesis in postmenopausal osteoporosis
8个月前
已完结
Vitamin D3exacerbates steatosis while calcipotriol inhibits inflammation in non-alcoholic fatty liver disease inSod1knockout mice: a comparative study of two forms of vitamin D
9个月前
已完结
皖公网安备34019202002308
